Logo image of CURR

CURRENC GROUP INC (CURR) Stock Fundamental Analysis

NASDAQ:CURR - Nasdaq - KYG478621009 - Common Stock - Currency: USD

0.6438  -0.15 (-18.42%)

Premarket: 0.6111 -0.03 (-5.08%)

Fundamental Rating

1

Overall CURR gets a fundamental rating of 1 out of 10. We evaluated CURR against 101 industry peers in the Financial Services industry. CURR may be in some trouble as it scores bad on both profitability and health. CURR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CURR had positive earnings in the past year.
CURR had a negative operating cash flow in the past year.
CURR Yearly Net Income VS EBIT VS OCF VS FCFCURR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

With a decent Return On Assets value of 3.95%, CURR is doing good in the industry, outperforming 72.28% of the companies in the same industry.
CURR's Return On Equity of 4.98% is on the low side compared to the rest of the industry. CURR is outperformed by 61.39% of its industry peers.
Industry RankSector Rank
ROA 3.95%
ROE 4.98%
ROIC N/A
ROA(3y)1.05%
ROA(5y)N/A
ROE(3y)1.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CURR Yearly ROA, ROE, ROICCURR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 -2 4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CURR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CURR Yearly Profit, Operating, Gross MarginsCURR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CURR has been reduced compared to 1 year ago.
CURR has a worse debt/assets ratio than last year.
CURR Yearly Shares OutstandingCURR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
CURR Yearly Total Debt VS Total AssetsCURR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that CURR is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.06, CURR is doing good in the industry, outperforming 62.38% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that CURR is not too dependend on debt financing.
CURR has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. CURR outperforms 89.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACCN/A
CURR Yearly LT Debt VS Equity VS FCFCURR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

CURR has a Current Ratio of 0.00. This is a bad value and indicates that CURR is not financially healthy enough and could expect problems in meeting its short term obligations.
CURR's Current ratio of 0.00 is on the low side compared to the rest of the industry. CURR is outperformed by 83.17% of its industry peers.
A Quick Ratio of 0.00 indicates that CURR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.00, CURR is doing worse than 83.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
CURR Yearly Current Assets VS Current LiabilitesCURR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

1

3. Growth

3.1 Past

CURR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.09%, which is quite impressive.
EPS 1Y (TTM)54.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CURR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -35.97% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-66.46%
EPS Next 3Y-35.97%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CURR Yearly Revenue VS EstimatesCURR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 10M 20M 30M 40M 50M
CURR Yearly EPS VS EstimatesCURR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.79, the valuation of CURR can be described as very cheap.
Based on the Price/Earnings ratio, CURR is valued cheaper than 96.04% of the companies in the same industry.
CURR is valuated cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.79
Fwd PE N/A
CURR Price Earnings VS Forward Price EarningsCURR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CURR Per share dataCURR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A cheap valuation may be justified as CURR's earnings are expected to decrease with -35.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-66.46%
EPS Next 3Y-35.97%

0

5. Dividend

5.1 Amount

CURR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CURRENC GROUP INC

NASDAQ:CURR (5/20/2025, 8:00:01 PM)

Premarket: 0.6111 -0.03 (-5.08%)

0.6438

-0.15 (-18.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-14 2025-08-14
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner Change0%
Market Cap29.96M
Analysts82.86
Price Target3.57 (454.52%)
Short Float %0.95%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.79
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)0.17
EY26.41%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.95
TBVpS0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.95%
ROE 4.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.05%
ROA(5y)N/A
ROE(3y)1.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 1.06
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67%
EPS Next YN/A
EPS Next 2Y-66.46%
EPS Next 3Y-35.97%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.24%
OCF growth 3YN/A
OCF growth 5YN/A